Apyx Medical (APYX) announced the launch of Renuvion in China as part of its international commercialization strategy. A targeted sales and marketing campaign for Renuvion is being conducted through a distribution agreement covering China with GlamMoon Medical Technology, the wholly owned equipment distribution division of BeauCare Clinics Investment, following receipt of initial market clearance from the National Medical Products Administration of China.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks